Astrazeneca to build huge new cancer drug plant in Singapore
Astrazeneca has said it would invest $1.5bn (£1.2bn) to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment. The FTSE 100 firm announced…